However, in an endotoxemia model in adult mice, KRN treatment increased survival, reduced serum levels of AST and ALT, and protected mice from BW loss when administered within 2 h before or after lipopolysaccharide (LPS) challenge (29). This evidence concerns the gene GPT and serum lipopolysaccharide activity.